GlaxoSmithKline Consumer Healthcare, Inc.
GlaxoSmithKline Consumer Healthcare, Inc. (GSK Consumer Healthcare) is a leading player in the global consumer health industry, headquartered in California. Founded in 2019, following the merger of GlaxoSmithKline's consumer health division with Pfizer's consumer healthcare business, the company has rapidly established itself in key operational regions, including North America, Europe, and Asia. GSK Consumer Healthcare focuses on a diverse range of products, including oral health, pain relief, respiratory health, and dietary supplements. Its portfolio features well-known brands such as Sensodyne, Panadol, and Voltaren, which are distinguished by their commitment to scientific innovation and consumer trust. With a strong market position, GSK Consumer Healthcare continues to achieve notable milestones, reinforcing its reputation as a leader in the consumer healthcare sector.
DitchCarbon Score
How does GlaxoSmithKline Consumer Healthcare, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GlaxoSmithKline Consumer Healthcare, Inc.'s score of 59 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GlaxoSmithKline Consumer Healthcare, Inc.'s reported carbon emissions
GlaxoSmithKline Consumer Healthcare, Inc., headquartered in California, currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. Despite the absence of emissions data, the company is likely engaged in various climate commitments and initiatives typical within the industry. Many organisations in the consumer healthcare sector are increasingly focusing on sustainability and reducing their carbon footprint. This often includes setting science-based targets for emissions reductions, enhancing energy efficiency, and investing in renewable energy sources. While specific reduction targets or achievements for GlaxoSmithKline Consumer Healthcare are not detailed, the company may be aligning with broader industry trends aimed at mitigating climate change impacts. As the landscape of corporate responsibility evolves, it is expected that they will adopt more transparent reporting and ambitious climate strategies in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GlaxoSmithKline Consumer Healthcare, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
